Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102-Reference-Cited by-同舟云学术

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

Published:2017-03 Issue:1 Volume:16 Page:51-57
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Hamauchi Satoshi,Yamazaki Kentaro,Masuishi Toshiki,Kito Yosuke,Komori Azusa,Tsushima Takahiro,Narita Yukiya,Todaka Akiko,Ishihara Makoto,Yokota Tomoya,Tanaka Tsutomu,Machida Nozomu,Kadowaki Shigenori,Fukutomi Akira,Ura Takashi,Onozawa Yusuke,Ando Masashi,Tajika Masahiro,Muro Kei,Yasui Hirofumi,Mori Keita,Taniguchi Hiroya

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference19 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

3. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;Karapetis;N Engl J Med,2008

4. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

5. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trifluridine/tipiracil with and without ramucirumab for advanced gastric cancer: a comparative observational study;Scientific Reports;2024-06-03

2. Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC;Trends in Cancer;2024-05

3. Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment;Oncology in Clinical Practice;2024-02-05

4. Risk factors and prognostic impact of severe neutropenia in the first cycle of trifluridine-tipiracil for metastatic colorectal cancer patients: A single-center retrospective study;2023-12-12

5. Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study;International Journal of Clinical Oncology;2023-08-14